Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
QJM : Monthly Journal of the Association of Physicians
|
August 1, 2007
Influence of prolonged hospitalization on overall bed occupancy: a five-year single-centre study
M P Quinn, A E Courtney, D G Fogarty, et al.
Clinical Chemistry
|
April 29, 1998
Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure
O Hasselwander, D McMaster, D G Fogarty, et al.
Diabetes
|
June 24, 2000
Segregation analysis of urinary albumin excretion in families with type 2 diabetes
D G Fogarty, L S Hanna, M Wantman, et al.
Diabetologia
|
February 10, 2009
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
G M Magee, R W Bilous, C R Cardwell, et al.
Atherosclerosis
|
April 20, 1999
HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
O Hasselwander, J McEneny, D McMaster, et al.
Diabetes
|
September 1, 1996
A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
D G Fogarty, J C Harron, A E Hughes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 10, 2010
Identifying additional patients with diabetic nephropathy using the UK primary care initiative
G M Magee, S J Hunter, C R Cardwell, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 23, 2013
Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
C J Hill, C R Cardwell, A P Maxwell, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 26, 1999
Homocysteine and B-group vitamins in renal transplant patients
J V Woodside, D G Fogarty, J H Lightbody, et al.
Cytokine
|
March 2, 1999
An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy
B V Loughrey, A P Maxwell, D G Fogarty, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
QJM : Monthly Journal of the Association of Physicians
|
August 1, 2007
Influence of prolonged hospitalization on overall bed occupancy: a five-year single-centre study
M P Quinn, A E Courtney, D G Fogarty, et al.
Clinical Chemistry
|
April 29, 1998
Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure
O Hasselwander, D McMaster, D G Fogarty, et al.
Diabetes
|
June 24, 2000
Segregation analysis of urinary albumin excretion in families with type 2 diabetes
D G Fogarty, L S Hanna, M Wantman, et al.
Diabetologia
|
February 10, 2009
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
G M Magee, R W Bilous, C R Cardwell, et al.
Atherosclerosis
|
April 20, 1999
HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
O Hasselwander, J McEneny, D McMaster, et al.
Diabetes
|
September 1, 1996
A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
D G Fogarty, J C Harron, A E Hughes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 10, 2010
Identifying additional patients with diabetic nephropathy using the UK primary care initiative
G M Magee, S J Hunter, C R Cardwell, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 23, 2013
Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
C J Hill, C R Cardwell, A P Maxwell, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 26, 1999
Homocysteine and B-group vitamins in renal transplant patients
J V Woodside, D G Fogarty, J H Lightbody, et al.
Cytokine
|
March 2, 1999
An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy
B V Loughrey, A P Maxwell, D G Fogarty, et al.
Page
of 3